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Abstract
Background: Transmembrane CAIX and CAXII are members of the alpha carbonic anhydrase
(CA) family. They play a crucial role in differentiation, proliferation, and pH regulation. Expression
of CAIX and CAXII proteins in tumor tissues is primarily induced by hypoxia and this is particularly
true for CAIX, which is regulated by the transcription factor, hypoxia inducible factor-1 (HIF-1).
Their distributions in normal adult human tissues are restricted to highly specialized cells that are
not always hypoxic. The human fetus exists in a relatively hypoxic environment. We examined
expression of CAIX, CAXII and HIF-1α in the developing human fetus and postnatal tissues to
determine whether expression of CAIX and CAXII is exclusively regulated by HIF-1.
Results: The co-localization of CAIX and HIF-1α was limited to certain cell types in embryonic
and early fetal tissues. Those cells comprised the primitive mesenchyma or involved
chondrogenesis and skin development. Transient CAIX expression was limited to immature tissues
of mesodermal origin and the skin and ependymal cells. The only tissues that persistently expressed
CAIX protein were coelomic epithelium (mesothelium) and its remnants, the epithelium of the
stomach and biliary tree, glands and crypt cells of duodenum and small intestine, and the cells
located at those sites previously identified as harboring adult stem cells in, for example, the skin
and large intestine. In many instances co-localization of CAIX and HIF-1α was not evident. CAXII
expression is restricted to cells involved in secretion and water absorption such as parietal cells of
the stomach, acinar cells of the salivary glands and pancreas, epithelium of the large intestine, and
renal tubules. Co-localization of CAXII with CAIX or HIF-1α was not observed.
Conclusion: The study has showed that: 1) HIF-1α and CAIX expression co- localized in many,
but not all, of the embryonic and early fetal tissues; 2) There is no evidence of co-localization of
CAIX and CAXII; 3) CAIX and CAXII expression is closely related to cell origin and secretory
activity involving proton transport, respectively. The intriguing finding of rare CAIX-expressing
cells in those sites corresponding to stem cell niches requires further investigation.
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Background
Carbonic anhydrases are metalloenzymes that are ubiqui-
tous in nature, being found in prokaryotes and eukaryotes
[1-3]. They are encoded by five distinct, evolutionarily
related gene families (α, β, γ, δ and ζ). The complexity of
the family membership increases with evolutionary
progress and, in mammals, which contain 16 α-CA iso-
zymes, the distribution of expression of family members
differs enormously, varying from expression in virtually
all cells (CAII) to very discrete temporal and tissue specific
expression (CAIX, CAXII and CAXIV). Furthermore, the
cellular localization of the CAs also varies, including cyto-
plasmic, mitochondrial, transmembrane and secreted [2-
9].
The transmembrane CAIX and, to a lesser degree, trans-
membrane CAXII, have received a great deal of attention.
This is because, in large measure, CAIX has been shown to
be an excellent cellular biomarker of hypoxia [7,10,11]
and a biomarker of certain malignancies, including renal
clear cell carcinoma [12,13] and cervical dysplasia and
carcinoma [14].
The association with hypoxia has been ascribed function-
ally to the fact that the CA9 promoter contains a hypoxia
response element (HRE) that is the target for the hypoxia
inducible factor 1 (HIF-1) transcription factor [10]. The
alpha subunit of the heterodimeric HIF-1 (HIF-1α) is rap-
idly degraded under normoxic O2 levels but is stable
under hypoxic conditions. Thus, HIF-1 is stable and tran-
scriptionally active predominantly in hypoxic tissues. This
close correlation between hypoxia and CAIX expression
has led to studies that have identified CAIX expression in
tumor cells that reside in hypoxic regions of solid tumor
tissues, i.e. those most refractory to radiation treatment
and certain drug modalities, as a potential therapeutic tar-
get [2,3,15].
Although it is clear that the CA9 gene is a transcriptional
target of HIF-1 there have been several studies that have
shown substantial but incomplete co-localization of CAIX
expression and regions of hypoxia in solid tumors, with
CAIX-positive areas extending beyond the region of
hypoxia [7,10,11]. Other studies also showed that CA9
transcription is up-regulated by extracellular acidosis
[7,16] and negatively controlled by an epigenetic mecha-
nism that involves methylation of the CA9 promoter [17].
In addition to transcriptional regulation, control of CAIX
expression may involve phosphatidyl inositol 3- kinase
(P13-kinase) activity [18] or alternative splicing of the
CA9 transcript [19].
Moreover, our previous studies also observed HIF-1α pos-
itive nuclear staining in squamous cells lining the oral
cavity, esophagus and cervix but no CAIX expression was
observed (data not shown). All of these studies would
suggest the possibility that transcriptional factors, other
than HIF-1, may modulate CAIX expression. Furthermore,
although CA12 was initially thought to be a HIF-respon-
sive gene [10], other evidence has questioned this correla-
tion [7,20]. Our previous study of CAIX and CAXII
expression in human tumor and normal adult tissues had
also showed that co-expression of CAIX and CAXII in
tumor tissue was mainly restricted to regions of hypoxia,
but in normal adult tissues CAIX and CAXII expression
did not appear to be induced only by hypoxia and seems
to be related to the functional status and cell origin of the
relevant tissue.
It has been well established that the mammalian embryo
and early stages of fetal development are hypoxic [21-24].
As the process of vascularization occurs hypoxic tissues
become progressively normoxic. Thus, the study of the
distribution of CAIX, CAXII and HIF-1α expression in the
developing human embryo and fetus would be an ideal in
vivo system in which to determine whether the postulated
coordination of hypoxia, HIF-1 activity and induction of
expression of CAIX and CAXII is seen, and also to test our
hypothesis that CAIX and CAXII expression may be
related to cell origin and secretory activity involving pro-
ton transport.
Results and Discussion
During embryonic development, cytotrophoblasts are
derived from the trophoblasts of the blastocyst. Later the
cytotrophoblasts, together with the coelomic membrane
and extraembryonic somatic mesoderm, constitute the
chorion. The extraembryonic somatic mesoderm forms
the connecting stalk (later becoming the umbilical cord).
During the 3rd week (gastrulation), many cells of the epi-
blast detach themselves from the neighboring cells and
form the mesoblast. The cells that remain in the epiblast
eventually form the embryonic ectoderm. Some of migrat-
ing mesoblastic cells organize and form the intraembry-
onic mesoderm and the notochord process. Some
mesoblastic cells form a loosely woven tissue of the
embryonic mesenchyme. These mesenchymal cells have
the potential to proliferate and differentiate into diverse
types of cells (fibroblasts, chondroblasts, osteoblasts,
myoblasts, etc.). At the end of the 3rd week, the intraem-
bryonic coelom develops from the lateral and cardiogenic
mesoderm and eventually gives rise to the body cavity
[25]. It is at this stage that we were able to obtain our ear-
liest embryonic tissue for analysis.
CAIX expression during the embryonic period (4 to 8 
weeks)
As early as at the 3rd to 4th week of gestation, CAIX
expression was already present in the cytotrophoblasts
(Fig. 1A, arrow) and rare mesenchymal cells of the chor-BMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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The embryonic period (4–8 weeks)  Figure 1
The embryonic period (4–8 weeks): CAIX expression was first seen in the cytotrophoblasts (A, arrow) and certain cells in 
the embryo (B), such as primitive mesenchyma (B1 long arrow), external surface of the embryo (B2, short double arrows), and 
mesenchymal cells of the chorion (B2, double long arrows). In the later embryonic stage, CAIX expression was primarily 
observed in the mesencyhmal cells involving chondrogenesis, as shown in the facial bone (C), bronchial tree (D), the limb (E), 
and the pelvic bone (F). All of the epithelial cells lining the body cavity were also positive for CAIX, e.g. the peritoneum (F), and 
the surface of the gonad (G). The only CAIX-positive cells in the CNS are ependymal cells (H). Original magnifications: A, B 
and H (20×); B1 and B2 (40×); C, D and F (4×); E and G (10×).BMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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ion and the connecting stalk. In the embryo there were
rare cells along the external surface (ectoderm) (Fig. 1B
and 1B2, short arrows) and in the primitive mesenchyme
(mesoblastic cells) that also weakly expressed CAIX (Fig.
1B1 and 1B2, long arrows). As gestation progresses,
increased levels of CAIX expression were seen in the basal
layer of the skin, and in the undifferentiated mesenchy-
mal cells of the embryo involved in chondrogenesis. At 7
to 8 weeks, high levels of CAIX expression were seen in the
perichondrial undifferentiated mesenchymal cells of the
skeletal system, such as facial bone (Fig. 1C), the tracheo-
bronchial cartilage (Fig. 1D), limbs and pelvic bone (Fig.
1E, 1F), and vertebrae (data not shown). All epithelial
cells (mesothelial cells) and underlying mesenchyma lin-
ing the body cavities showed varying degrees of CAIX
expression (Fig. 1F, 1G). As mentioned above, at the 3rd
to 4th week of gestation there were only a relatively few
weakly positive CAIX expressing cells identified in the
embryo, and some of these cells appeared to locate near
the neural plate. At 7 to 8 weeks of gestation, the only cells
in the nervous system that expressed CAIX were the prim-
itive ependymal cells, derived from the neural crest cells
(Fig. 1H). It is worth noting that no other embryonic cells,
besides the cells described above, expressed CAIX. For
example, CAIX expression was not seen in the lung, heart
(Fig. 1D), intestine (Fig. 1F), kidney or gonad (Fig. 1G).
CAIX expression during fetal development (9 to 40 weeks)
During the fetal stage, CAIX expression was closely related
to the cell origin (coelomic derivatives), state of cell differ-
entiation, microenvironmental pH status and, to a large
degree, the condition of hypoxia. Those tissues expressing
CAIX during the embryonic period continued to retain
high levels of CAIX expression during the first to 2nd tri-
mester. However, with a few exceptions (body cavity lin-
ing cells, coelomic derived remnants, and the
gastrointestinal tract), the levels of CAIX expression pro-
gressively diminished after 29–30 weeks of gestation and
eventually vanished during the postnatal period. After the
age of one year, CAIX expression is similar to that
observed in normal adult tissues [7]. The details are as fol-
lows:
Placenta
High levels of CAIX expression in the mesenchymal cells
of the connecting stalk/umbilical cord (Fig. 2A1) and the
chorionic plate (Fig. 2A2) were persistent throughout fetal
development to term pregnancy. No CAIX immunoreac-
tivity was observed in the chorionic villi.
The body cavity
The mesothelial cells lining the body cavities and the sur-
faces of visceral organ system showed high levels of CAIX
expression throughout the developmental stages of the
fetus and continued into adulthood [7]. Representative
examples are shown in figs 1F, 1G, 3B, 3G1, and 3G2.
The skin and squamous mucosa
During the fetal period the basal cells of the skin continu-
ously proliferate and eventually form the hair follicle, and
the sebaceous, apocrine and eccrine units. In the early
fetal stage, increasing CAIX expression was seen along the
basal layer and the hair bud; however, no expression of
CAIX was seen in the hair bulb and condensation of mes-
enchyma (Fig. 2B1). Around 16 to 17 weeks of gestation,
high levels of CAIX expression were seen in the basal cells,
sebaceous unit, the bulge of the prospective site of attach-
ment of the erector muscle, and the outer sheath of the
hair follicle (Fig. 2B2). The expression was persistent
throughout the fetal period, but progressively diminished
during the postnatal period. 18 to 24 months after birth,
CAIX immunoreactivity was similar to that seen in the
adult skin and was concentrated in the outer sheath of
hair follicles, the sebaceous unit and the infundibulum of
the hair follicle (Fig. 2C). However, scattered CAIX posi-
tive cells were also present along the basal layer between
the infundibulo-sebaceous-apocrine units (data not
shown). Besides the skin, the dental lamina, enamel
organ and the basal cells of the squamous mucosa of the
nose, the oral cavity, esophagus and the genital organ sys-
tem, including the cervix, vagina and anus, also showed
variable degrees of CAIX expression, ranging from expres-
sion limited to a few basal cells (data not shown) to dif-
fuse basal cell positivity, as shown in fig 2D (the nose at
17 weeks of gestation). After 26 weeks, the levels of CAIX
expression progressively diminished. At one year of post-
natal age, CAIX expression was restricted to a few basal
cells. However, increased levels of CAIX expression in the
reparative basal cells were noticed when there was tissue
repair due to injury or inflammation (data not shown).
The articular, skeletal and muscular system
There was progressively increased intensity of CAIX
expression in the mesenchymal cells involved in chondro-
genesis. By the 9th to 11th week of gestation, high levels
of CAIX expression were seen in the primitive mesen-
chyme and chondroblasts in most parts of the skeletal sys-
tem, especially in the articular disc of the vertebrae (Fig.
2E), the condensation of the mesenchyme around the
immature cartilage of the limbs/facial bone (Fig. 2F, 2G),
the primitive mesenchymal cells of tendoligamentous
units (Fig. 2H) and the tracheobronchial trees (Fig. 3A1).
These areas have been shown by us (data shown later) and
others [24] to be predominantly hypoxic; thus, CAIX
expression in these areas is most likely due to HIF-1 medi-
ated gene expression. In the muscular system, CAIX posi-
tivity was observed around the 10th week of gestation.
Although the levels of CAIX expression in the muscular
system varied among the visceral organs it was oftenBMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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CAIX expression in the placenta, skin, squamous mucosa and skeletal system Figure 2
CAIX expression in the placenta, skin, squamous mucosa and skeletal system. The mesenchymal cells of the chori-
onic plate and umbilical cord retained their CAIX expression until birth (A1, A2). In the epidermis, CAIX expression was lim-
ited to the basal layer (B1, F), hair buds (B1) and sebaceous units, hair follicles and the bulges (B2, arrow and inserts). Between 
18 to 24 months after birth, CAIX expression was restricted to the hair follicles, sebaceous units, and the infundibulum (C). In 
the skeletal system, persistent high levels of CAIX immunoreactivity was seen in the chondrocytes, mesenchymal condense (E, 
F, G) and tendoligamental tissues (G, H). The basal layer of squamous mucosa of the nose (D) and oral cavity (G) also 
expressed CAIX. W = gestational age in weeks; M = postnatal age in months. Original magnifications: A1, A2, B, C and H 
(20×); D and G (4×); E (10×) and F (40×).BMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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CAIX expression in bronchial trees and genital organs Figure 3
CAIX expression in bronchial trees and genital organs: In the bronchial trees high expression of CAIX was seen in the 
peribronchial immature mesenchymal cells and cartilage (designated C) (A1) but progressively diminished when the tissues 
became mature (A2, A3). CAIX positivity was persistently seen in peritoneal lining cells as shown in B (insert) and G1, G2 (sur-
face epithelium [SE], arrow). As early as the 13th week of gestation, CAIX positive cells were seen in the flat SE of the ovary, 
the outer muscular layer and rare epithelial cells of the uterus and fallopian tubes (B). Around 26 to 27 weeks, high levels of 
CAIX expression were transiently seen in the epithelium of fallopian tubes (C1), endometrium (D1), and the cervix (E1). After 
birth, there was either no CAIX expression (C3) or expression was limited to occasional endometrial cells (D2), reserve cells 
of the cervix (E2, and corresponding H&E stain in insert, and F1, F2). In the ovary, CAIX expression was observed in SE migrat-
ing into the stroma and forming the primordial follicle (PF) (G1, G2). Persistent expression of CAIX was observed in the coe-
lomic remnants: rete testis (H1) and tubule reti (H2). W = gestational age in weeks; D, M = postnatal age in days and months, 
respectively. Original magnifications: A1, A2, A3, C1, C2, C3, E1, E2 and F2 (20×); B (4×); H1 and H2 (10×); D1, D2, F1, G1 
and G2 (40×).BMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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observed in peritracheal primitive muscle cells (Fig. 3A2),
the external layer of the muscular propria of the genitouri-
nary tract (Fig. 3B) and the gastrointestinal system, the
aorta, and focally in cardiac muscle (data not shown). All
of these tissues are derived from the splanchnic mesen-
chyma. In addition, in the heart there were specialized
mesenchymal cells (coelomic origin) at the atrioventricu-
lar junction that also expressed CAIX (data not shown).
After 20 weeks of gestation, CAIX expression progressively
diminished and eventually disappeared when these mes-
enchymal cells differentiated into mature cartilage, joint
capsule, ligament, synovium, and muscular propria of all
visceral organs. An illustrative example of the progressive
loss of CAIX expression during cell maturation is shown
in Fig. 3A. Diffuse CAIX expression was seen in the peri-
tracheobronchial primitive mesenchyma (Fig. 3A1). In
the relatively well developed lung (after 17 weeks), CAIX
expression was limited to the immature peritracheobron-
chial muscle and perichondrial mesenchymal cells (Fig.
3A2). After birth to one year of age, CAIX expression was
no longer present in the cartilage or muscle (Fig. 3A3).
The genital system
During fetal development, all of the genital organs
derived from the coelom and paramesonephric ducts
(Müllerian duct) showed variable degrees of CAIX expres-
sion. These levels of expression can basically be divided
into three periods (13 to 24 weeks; 25 to 28 weeks; and 29
weeks to birth). As early as at the 13th week of gestation,
CAIX expression was identified in the primitive muscular
layer of the uterus and fallopian tubes (Fig. 3B), the flat
surface epithelium (modified mesothelium) of all male
and female genital organs (Fig. 3B insert), and in rare epi-
thelial cells of the endometrium, cervix and fallopian
tubes. By the end of the 2nd trimester (24 weeks), there
was no longer any observable CAIX expression in the mus-
cular propria. However, there were transient increased lev-
els of CAIX expression in the epithelial cells of the
fallopian tube (Fig. 3C1), endometrium (Fig. 3D1), cervix
(Fig. 3E1) and vagina during 26 to 28 weeks of gestation.
CAIX expression progressively diminished after 29 weeks
but the levels of expression appear to vary from case to
case. Usually near or after one year of age, CAIX expres-
sion was either extinguished, as seen in the fallopian tube
(Fig. 3C3), or restricted to rare columnar cells of the
endometrium (Fig. 3D2). In the cervix, high levels of
CAIX expression were persistently observed in the reserve
cells (Fig. 3E2) and, to a lesser degree, in columnar cells at
1–2 months postnatally. Between 2–12 months postna-
tally, CAIX expression was restricted to rare reserve cells
(Fig. 3F1, 3F2). In contrast, throughout the fetal period
CAIX was persistently expressed in the flat surface epithe-
lium of all genital organs and the coelomic derived rem-
nants, such as the rete ovarii, rete testis and tubuli reti, the
hydatid of Morgagni, and the appendix of the testis. Inter-
estingly, the efferent ductules that merged into the rete tes-
tis also showed diffuse immunoreactivity for CAIX.
Representative illustrations are shown in figs 3G1, 3G2
(ovarian surface and primordial follicles), and figs 3H1,
3H2 (the rete testis and tubule reti). With the exception of
mature follicles of the ovary, these expression patterns are
continuously seen throughout adult life [7]
The urinary system
The urinary organs consist of the kidneys, ureters, urinary
bladder, prostate and urethra. The kidneys and ureters are
derived from the metanephrons, whereas the epithelium
of the bladder, prostate and urethra are derived from the
endoderm. With the exception of efferent ductules as
described above, CAIX expression was limited to a few
prostate terminal glands and rare primitive reserve cells of
the urothelial epithelium (data not shown).
The endocrine and hematopoietic system
None of the endocrine organs and hematopoietic systems
expressed CAIX, with the exception of the adrenal cortical
cells and the thymus gland. The proliferation of the coe-
lomic epithelium initially forms the fetal cortex of the
adrenal glands. Around 8 weeks of gestation, more coe-
lomic epithelial cells proliferate and constitute the perma-
nent cortex. CAIX immunostaining in the adrenal cortical
cells was first seen around 12–14 weeks of gestation and
reached its highest levels of expression during gestational
age of 20–28 weeks. The CAIX immunoreactivity was per-
sistent until birth but the numbers of positive cortical cells
progressively decreased. By the end of 2 years, no CAIX
positive cells were identified in the adrenal glands. Repre-
sentative illustrations of this temporal sequence of expres-
sion are shown in fig 4A. The developing thymus gland
comprises the mesenchyme, hematopoietic stem cells and
the epithelial cell cords derived from the third pair of
endodermal pharyngeal pouches. At the 13th week of ges-
tation, scattered CAIX positive cells were identified near
the Hassall's corpuscles. After the 17th week of gestation,
high levels of CAIX expression extended to the surface of
the lobules (Fig. 4B, 16 weeks). The cells that expressed
CAIX did not appear to co-express cytokeratin (data not
shown). From this we speculate that these CAIX positive
cells were probably immature mesenchymal cells rather
than thymic epithelial cells. As the thymus progressively
matured the numbers of CAIX positive cells decreased
and, after the age of one year, no CAIX expression was
seen in the thymus (Fig. 4B, 24 Months).
The epithelial cells of the respiratory and gastrointestinal systems 
(endodermal derivatives)
CAIX expression in the GI system was persistent through-
out fetal development. CAIX immunoreactivity was first
observed in surface columnar cells of the stomach (Fig.BMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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4C), and the crypt cells of the duodenum at 9–12 weeks
of gestation. After 16–17 weeks CAIX expression was
restricted to certain epithelial cells along the GI system,
including gastric glandular cells, neck mucous cells and
fundic glandular cells (Fig. 4C), the pyloric and Brunner's
glands; the crypt cells of the duodenum and small intes-
tine (Fig. 4D1); and the appendix. The numbers of CAIX
immunostained crypt cells were significantly decreased in
the distal part of the small intestine. CAIX expression in
the large intestine was limited to rare cells in the crypts
and was not clearly identified until late in the third trimes-
ter. After birth, the numbers of positive cells in the large
intestine varied from case to case, but were consistently
located near the bottom of the crypts (Fig. 4D2). High lev-
els of CAIX expression were seen in the ductal cells of the
entire biliary system, including bile ducts of the liver (Fig.
4E1), common bile ducts, gallbladder, and pancreatic
ducts (Fig. 4E2). In the esophagus and the respiratory sys-
tem, CAIX expression was seen diffusely distributed in the
basal/reserve cells of the squamous and respiratory
mucosa during the early fetal period (Fig. 4F1) but, after
birth, the expression progressively decreased. At the age of
one year and thereafter, CAIX immunoreactivity was lim-
ited to a few basal cells of the squamous mucosa and
primitive reserve cells of the respiratory epithelium (Fig.
4F2).
The nervous system
During fetal development the only cells in the nervous
system that expressed CAIX were the immature ependy-
mal cells and leptomeningeal loose connective tissues of
mesoderm derivatives. Its expression was persistent
throughout the fetal period.
CAIX expression during the postnatal period (after birth to 
8 years old)
During the postnatal period (especially after one year of
age) and throughout adult life [7], CAIX expression was
no longer present in the normal tissues, with the follow-
ing exceptions: 1) persistent CAIX expression in mesothe-
lial cells of the body cavity, the surface flat epithelium of
all visceral organs, the rete ovarii, rete testis, tubuli reti, the
hydatids of Morgagni, the appendix of the testis and effer-
ent ductules. With the exception of efferent ductules, all of
these CAIX positive organ systems are derived from coe-
lomic epithelium; 2) persistent high levels of CAIX expres-
sion in the GI system, comprising the gastric surface
epithelium, gastric glands, pyloric/Brunner's glands, crypt
cells of the small intestine, and the biliary trees, including
the gallbladder; 3) high levels of CAIX expression in the
infundibulum and the outer sheath of hair follicles, and
the sebaceous units of the skin; 4) variable degrees of
CAIX expression in the primitive reserve cells or immature
metaplastic squamous cells of the lining epithelium of all
visceral organs and rare columnar cells in the crypts of the
large intestine. Interestingly, in the reparative squamous
or respiratory mucosa, not only do the numbers of basal/
reserve cells expressing CAIX appear to increase, CAIX
expression is also observed in rare columnar cells; and 5)
the only mesenchymal tissues that retained CAIX expres-
sion after birth were the submesothelial stromal cells, the
meniscus and the nucleus pulposus of the vertebrae. Sche-
matic representations of the temporal and tissue-specific
distribution of CAIX expressing cells, both pre- and post-
natal, are shown in Figs 5 and 6. The patterns of expres-
sion clearly indicate that, during human development, all
of the CAIX positive cells were derived from the meso-
derm and were particularly related to the embryonic coe-
lom and mesenchyme, with the exception of the skin,
squamous mucosa, the upper gastrointestinal tract and
the efferent ductules.
CAXII expression during human development
In contrast to CAIX, the expression of CAXII was limited
to very few organ systems. The numbers of cells stained
and the intensity of positive staining were consistent
throughout the embryonic and fetal periods and into the
entire adult life. Its expression was observed predomi-
nantly in cells derived from the mesonephric duct or those
cells whose differentiated function involves secretion and
proton pumping. The coelomic cell origin, cell differenti-
ation and degree of cellular hypoxia (the latter playing a
significant role in regulation of CAIX expression), proba-
bly play no significant role in regulation of CAXII expres-
sion. CAXII expression was first observed in
syncytiotrophoblasts during the embryonic period.
Between 7–12 weeks of gestation, high levels of CAXII
expression were already seen in those tissues involved in
secretion or pH regulation. For example, the taste buds
and underlying glands of the tongue (Fig. 7A), pancreatic
acinar cells (Fig. 7B) and acinar cells of the minor/major
salivary glands, the parietal cells of the stomach (Fig.
7C1), the epithelium of the large intestine (Fig. 7D1),
renal tubules (Fig. 7E1), and choroid plexus (Fig. 7F1).
CAXII expression was also observed in the remnants of
mesonephric ducts of the testis and the ovary (Fig. 7G),
and the epithelium of the inner ear (data not shown). Var-
iable degrees of CAXII immunopositivity were also
observed in the basal cells of the respiratory mucosa and
the squamous mucosa lining the oral cavity, esophagus,
cervix, vagina and the anus (data not shown). All of the
tissues that expressed CAXII during fetal development
retained their expression after birth and throughout adult
life [7]. A representative comparison of expression of
CAIX and CAXII proteins is shown in figs 7C–7H. It
appears that the majority of organ systems show no co-
expression of CAXII and CAIX.BMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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In the adrenal gland (A), strong CAIX immunoreactivity was seen in many cortical cells near the capsule (17W), but the level of  expression progressively diminished after birth and, by the end of two years, no CAIX positive cells were seen Figure 4
In the adrenal gland (A), strong CAIX immunoreactivity was seen in many cortical cells near the capsule 
(17W), but the level of expression progressively diminished after birth and, by the end of two years, no CAIX 
positive cells were seen. In the thymus gland (B), CAIX positive cells were primarily identified near the Hassall's corpuscles 
(16W) but disappeared by the first year after birth (24M). In the stomach (C), CAIX expression was first seen in surface 
columnar cells at the 9th week of gestation (9W). At 17 weeks, diffuse immunoreactivity was seen in the glandular and surface 
columnar cells (17W). This level of expression persisted after birth (24M). In the small intestine CAIX positive cells were 
restricted to the crypts (D1) and in the large intestine only rare positive cells were identified near the base of the crypts (D2). 
In the biliary trees, CAIX expression was seen in the epithelium of the entire ductal system and was persistent after birth. The 
liver (E1) and pancreas (E2) are shown as examples. During early fetal period, extensive CAIX expression was seen in the 
basal/reserve cells of the respiratory epithelium (F1, 14W) but after birth only rare reserve cells continued to express CAIX 
(F2, 24M). W = gestational age in weeks; D, M = postnatal age in days and months, respectively. Original magnifications: A1, 
A2, A3, B1 and C (20×); B2, D1, D2, E1, E2, F1 and F2 (40×).BMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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Correlation between CAIX and HIF-1α expression during 
human development
Recent evidence indicates that the fetus exists in a rela-
tively hypoxic environment. The fetal PO2 is 35 mm of Hg
compared with 100 mm of Hg in the adult [23]. HIF-1α
mRNA is constitutively expressed in all organs and at all
stages of gestation from 14–22 weeks, with the highest
expression noted in the brain, heart, kidney, lung and
liver [23]. However, HIF-1α protein is rapidly degraded in
the proteasome, via VHL E3 ligase recognition, under nor-
moxic conditions and is stabilized under hypoxic condi-
tions [2,3]. In the transgenic mouse model study
conducted by Provot et al., they found that HIF-1α protein
is stably expressed and transcriptionally active in limb
bud mesenchyme and in mesenchyme condensations
during fetal development [24]. Thus, HIF-1 appears to
play an important role in early chondrogenesis and joint
formation. We performed an immunohistochemical
study for HIF-1α expression on the fetal tissues, represent-
ing all stages of human development from 5–38 weeks of
gestation, and encompassing both embryonic and fetal
development. We found that as early as 5–9 weeks of ges-
tation, diffuse HIF-1α nuclear immunoreactivity was seen
in most of the embryonic and fetal tissues, particularly in
the endothelial cells, body mesenchymal cells and nerv-
ous system (Fig. 8A), primitive gastrointestinal tract (Fig.
8B), and the chondrocytes and mesenchyme of vertebral
disc/limb bud (Fig. 8D, 8E). In the skin, HIF-1α expres-
sion was consistently observed during fetal development
(Fig. 8E, 8H). Interestingly, the immature chorionic villi
during the 1st trimester also showed diffuse HIF-1α
nuclear staining (Fig. 8C) and this observation is consist-
ent with that previously published [26]. Variable degrees
of HIF-1α expression were also observed in the visceral
organs, especially during 17–25 weeks of gestation. The
best examples are shown in fig 8F (kidney) and 8G (rec-
Schema of CAIX expression in the cytotrophoblast and extra-/intra-embryonic mesoderm derivatives during human develop- ment (embryonic, fetal and postnatal periods) Figure 5
Schema of CAIX expression in the cytotrophoblast and extra-/intra-embryonic mesoderm derivatives during 
human development (embryonic, fetal and postnatal periods).BMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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tum). Although HIF-1α expression was persistent
throughout the fetal period, the numbers of expressing
cells progressively diminished. During the last trimester of
fetal development (27–40 weeks) stable HIF-1α expres-
sion was limited to chondrocytes, endothelial cells, skin,
and epithelial cells of the squamous mucosa, such as the
vagina and cervix (Fig. 8I, 8J), the oral cavity, esophagus
and anus.
It has been established that CAIX is an endogenous cellu-
lar hypoxia marker in solid tumor tissues, and that HIF-1α
is an important factor in the regulation of CAIX expression
[2-8]. This correspondence between HIF-1α and CAIX
expression was also seen in this study in certain cell types
during the embryonic period to early stage of fetal devel-
opment, and between 17–25 weeks of gestational age.
During the embryonic and early fetal periods, those cells
comprising the primitive mesenchyme, or involving
chondrogenesis and skin development, expressed high
levels of CAIX. These CAIX positive primitive cells either
co-expressed HIF-1α or were located adjacent to HIF-1α
expressing cells. The best examples were the embryonic
mesenchyme and chondrocytes of the vertebrae, limb
buds, and basal cells of the skin (Fig. 8D, 8E, 8H). In the
17–28 week gestation period, there were transient high
levels of CAIX expression in the epithelial cells derived
from the coelom and the basal layer of the squamous
mucosa. Some, but not all, of those CAIX-positive epithe-
lial cells also showed nuclear immunostaining for HIF-1α;
for example, vaginal squamous mucosa and the cervix
(Fig. 8I, 8J). The findings appear to indicate that CAIX
expression in the developing fetal tissues is partially under
the influence of hypoxia. However, it is important to note
that not all of the cells expressing CAIX protein were nec-
Schema of CAIX expression in the ectodermal and endodermal derivatives during human development (embryonic, fetal and  postnatal periods) Figure 6
Schema of CAIX expression in the ectodermal and endodermal derivatives during human development 
(embryonic, fetal and postnatal periods).BMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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Comparison of CAIX and CAXII expression during human development Figure 7
Comparison of CAIX and CAXII expression during human development. There is no correlation between CAXII 
and CAIX expression. CAXII positive cells were distributed in taste buds and the submucosal gland of the tongue (A, 17W), 
the acinar cells of the pancreas (B, lower panel, but not ductal cells [B, upper panel]), the parietal cells but not columnar cells 
of the stomach (C1, 27W), the large intestine (D1, 17W), the distal tubules and collecting ducts of the kidney (E1, 8W), the 
choroid plexus (F1, 8W) and the remnants of mesonephric ducts of the ovary (G, 13W). In contrast, CAIX positive cells were 
seen in the gastric columnar cells (C2, 27W), the ependymal cells (F2, 8W), and the surface epithelial cells of the ovary and 
peritoneum (H, 13W). However, CAIX expression was not seen in the large intestine (D2, 17W), kidney (E2, 8W) and the 
remnants of the ovarian mesonephric ducts (H, 13W). W = gestational age in weeks. Original magnifications: A, F1 and F2 
(20×); B, C1, C2, D1 and D2 (40×); E1, E2, G and H (10×).BMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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essarily related to the hypoxic condition and, conversely,
not all of the hypoxic cells (as indicated by stable HIF-1α
expression) expressed CAIX. For example, the trophob-
lasts of the chorionic villi were hypoxic and showed dif-
fuse nuclear immunoreactivity for HIF-1α, as shown by us
and others, but were negative for CAIX expression (Fig.
8C).
The embryonic and fetal tissues during 5–12 weeks of ges-
tation were uniformly hypoxic. By immunohistochemical
study, high levels of HIF-1α expression was seen in most
of the fetal tissues but no CAIX expression was present in
the majority of visceral organs; for example, the primitive
nervous system (Fig. 8A), kidney (Fig. 8F), gastrointestinal
tract (Fig. 8B, 8G), lungs, cardiac muscle, and liver (data
not shown). In contrast, during late fetal development
there were epithelial cells of coelomic derivatives, stom-
ach, biliary system, crypt cells of the intestine and squa-
mous mucosa of the cervix, vagina that exhibited high
levels of CAIX expression; however, no HIF-1α nuclear
staining was seen in those CAIX positive tissues, with the
exception of squamous mucosa of the cervix and vagina,
as noted above.
It has been shown that CAIX expression in the gastrointes-
tinal tract is not only involved in maintenance of tissue
integrity and regulation of basolateral ion transport but is
also closely related to cell proliferation and differentiation
[27]. Thus, we also performed Ki67 immunostaining, a
marker of cellular proliferation, in selected cases to deter-
mine whether the postulated coordination of proliferative
activity and CAIX expression is seen. In this study, we
found that the majority of CAIX positive cells were not in
the proliferative stage (data not shown).
Conclusion
Although CAIX and CAXII expression during mouse
embryonic development has been previously described
[28], a systematic comparative study of CAIX, CAXII and
HIF-1α expression in the embryonic, fetal and postnatal
tissues during human development has not been
reported. We find that the distributions of CAIX and
CAXII immunoreactivity in the mouse tissues are similar
but not identical to the immunoreactive patterns observed
in the human organs. For example, staining for CAIX in
the mouse embryos showed a relatively wide distribution
pattern with moderate signals in the brain, lung, pancreas
and liver, and weak expression in the kidney and stomach
[28]. In human fetal tissues, CAIX expression in those
organ systems was restricted to certain cell types, such as
the primitive ependymal cells of the brain, immature mes-
enchymal cells of the bronchial tree system, and epithelial
cells of the pancreatic ducts and stomach. High levels of
CAXII expression were seen in the choroid plexus in both
mouse and human tissues, but CAXII expression in the
embryonic mouse kidneys and other organs was weak and
became negative in the adult mice. In contrast, the inten-
sity of CAXII expression in the human fetal tissues persists
postnatally throughout the adult lifespan.
Several intriguing features concerning CAIX expression
have emerged from the study of the developing human
embryo and fetus. As expected, HIF-1α and CAIX expres-
sion colocalized in many, but not all, of the embryonic
and early fetal tissues. As fetal development progressed,
and vascularization increased, the lack of co-expression of
HIF-1α and CAIX became more apparent in multiple tis-
sues. In those instances where HIF-1α is not expressed but
CAIX is, one must assume that its expression is regulated
by other transcriptional factors. We, and others [16,29],
have shown that SP1 is required.
Furthermore, transcription mediated indirectly by P13-
kinase activity may also be a possibility [18]. Of particular
interest is the situation where HIF-1α is stably expressed
but no CAIX expression is found. Stable inactive HIF-1α
expression has been noted in the presence of proteasome
inhibitors [30]. One possibility is the expression of a co-
repressor inhibiting the activity of HIF-1. Another impor-
tant factor in the regulation of CAIX expression is the cell
origin. CAIX expression was consistently observed in cells
derived from the coelomic epithelium. The best examples
are mesothelial cells, modified mesothelial cells (Mülle-
rian epithelium), underlying mesenchymal cells lining
the body cavity, and coelomic remnants, such as the rete
ovarii, rete testis and tubuli reti, the hydatid of Morgagni
and the appendix of the testis. Another feature of the reg-
ulation of CAIX expression is its pH control function.
CAIX is a transmembrane carbonic anhydrase that pos-
sesses cell surface enzyme activity that catalyzes the con-
version of CO2 into bicarbonate and protons [31]. Thus,
the CAIX expression observed in the gastrointestinal tract
is more likely induced by cellular acidity and the require-
ment for proton transport.
Although CAXII expression was originally thought to be
regulated by HIF-1 [10], this is clearly not the case. There
is no obvious co-localization of HIF-1α and CAXII.
Furthermore, there is also no co-localization of CAIX and
CAXII. The distribution of CAXII expression would sug-
gest that it plays an important physiological role in secre-
tory/absorptive cells in different organ systems, primarily
involving ion transport and fluid concentration. Corrobo-
rating this suggestion is a previous study that found that
CAXII is overexpressed in the ciliary epithelial cells of
glaucomatous eyes and may be involved in aqueous
humour production [32].BMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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The correlation between CAIX and HIF-1α expression during human development Figure 8
The correlation between CAIX and HIF-1α expression during human development. In the early stage (5–9 weeks 
of gestation) diffuse HIF-1α immunoreactivity was seen in the CNS (A), primitive intestine (B), chorionic villi (C) and chondro-
cytes of the disc (D), mesenchymal cells and chondrocytes of the limb (E), and the skin (E arrow). In contrast, no CAIX expres-
sion was seen in the CNS (A), primitive intestine (B), and chorionic villi (C). Co-expression of HIF-1α and CAIX was seen in 
the skin (E) and the cells involved in chondrogenesis (D, E). During later human development, around 19–20 weeks, HIF-1α 
expression was persistently observed in the kidney (F) and rectum (G) but no CAIX expressing cells were seen in these 
organs. However, a degree of overlap between CAIX and HIF-1α expression was seen in the skin (H), squamous mucosa of 
the vagina and the cervix (I and J). W = gestational age in weeks. Original magnifications: A, B, D-H (40×); C (left panel 20×; 
right panel 40×); I (20×); J (left panel 20×; right panel 40×).BMC Developmental Biology 2009, 9:22 http://www.biomedcentral.com/1471-213X/9/22
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A particularly intriguing finding was the discrete distribu-
tion of CAIX expression in rare cells or niches in late stages
of fetal development, and postnatally, that correspond to
sites previously identified as harboring adult stem cells.
For example, CAIX expression in the skin is restricted to
the hair follicles, including the bulge, sebaceous gland,
outer root sheath and infundibulum, plus rare cells in the
inter-follicular zone. This corresponds to epidermal stem
cell niches that have been described, using various stem
cell biomarkers [33,34]. Also, the distribution of CAIX
expression in the small and large intestine is very similar
to that described for the identification of the intestinal
stem cell niche, using the Lgr5 biomarker [35]. Finally,
our observation of CAIX expression in Müllerian-type
columnar cells and reserve cells of the cervix, during fetal
development and postnatally, appears to be similar to
that described in the study conducted by Martens and col-
leagues [36]. These authors claim that the Müllerian epi-
thelial cells represent the stem cells for endocervical
reserve cells and columnar cells. Thus, we hypothesize
that the rare reserve cells expressing CAIX in the cervix and
other organ systems may correspond to putative stem cell
regions. However, at this time, such distributions and
their relevance to stem cell identity are speculative and
will require more comparison and functional analyses.
These studies are in progress. If CAIX is found to be a stem
cell marker for certain tissues it will be an attractive one.
Its transmembrane location will be extremely useful for
cell sorting analyses. It may also provide a caveat for can-
cer therapeutic regimens that target CAIX-expressing cells
for destruction [37].
Methods
Tissue specimens
The embryonic, fetal, and postnatal tissues were collected
at St. Joseph Hospital (Orange, CA) from 1997 to 2005.
The sources of these specimens included spontaneously
abortive embryos, stillborn fetuses and organs of autopsy
cases. Consent was obtained prior to any medical proce-
dures being performed. The extra-tissue sections were pre-
pared and labeled precisely according to the age
distribution without any identification. The studied cases
included 10 from the embryonic period (4 to 8 weeks), 42
from the fetal period (9 weeks to birth) and 26 from the
postnatal period (one day to 8 years old). The cases from
the fetal period were further divided into 9 to 12 weeks (5
cases), 13 to 16 weeks (9 cases), 17 to 20 weeks (7 cases),
21 to 25 weeks (4 cases), 26 to 40 weeks (17 cases). All of
the tissues were fixed in 10% neutral-buffered formalin,
paraffin-embedded, sectioned, and stained with hematox-
ylin and eosin (H&E).
Immunohistochemical studies
The mouse monoclonal antibody (M75) used to detected
the MN/CAIX protein and the rabbit polyclonal antibody
to CAXII have been described previously and both anti-
bodies have been shown to be specific for CAIX and
CAXII, respectively [38,39].
Immunohistochemical staining of tissue sections with
anti-CAIX and anti-CAXII antibodies was done using a
peroxidase technique with a pressure cooking pretreat-
ment.
The peroxidase method and the primary antibody dilu-
tion for CAIX (1:10,000) and CAXII (1:500) have been
described previously [7,12,14]. For CAXII immunostain-
ing, the avidin-biotin enzyme complex Kit (LSAB2, DAKO
Corp., Carpinteria, CA) was used. Positive and negative
controls were included in each run. Anti-HIF-1α (Neo-
Markers INC. Fremont, CA, USA) and anti-Ki67 (Dako)
mouse monoclonal antibodies at a 1:100 dilution, respec-
tively, were also applied to selected cases. For HIF-1α, the
sections were exposed to pressure cooking pretreatment in
citrate buffer (pH 6.0) for 15 min and the DAKO Cata-
lyzed Signal Amplification System (CSA) was used accord-
ing to the manufacturer's instructions.
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